253 related articles for article (PubMed ID: 8527482)
1. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
Kun LE; Gajjar A; Muhlbauer M; Heideman RL; Sanford R; Brenner M; Walter A; Langston J; Jenkins J; Facchini S
Hum Gene Ther; 1995 Sep; 6(9):1231-55. PubMed ID: 8527482
[TBL] [Abstract][Full Text] [Related]
2. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
[TBL] [Abstract][Full Text] [Related]
3. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL
Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.
Raffel C; Culver K; Kohn D; Nelson M; Siegel S; Gillis F; Link CJ; Villablanca JG; Anderson WF
Hum Gene Ther; 1994 Jul; 5(7):863-90. PubMed ID: 7981311
[No Abstract] [Full Text] [Related]
6. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
Oldfield EH; Ram Z; Culver KW; Blaese RM; DeVroom HL; Anderson WF
Hum Gene Ther; 1993 Feb; 4(1):39-69. PubMed ID: 8384892
[TBL] [Abstract][Full Text] [Related]
8. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
Klatzmann D
Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
11. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
12. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients.
Alvarez RD; Curiel DT
Hum Gene Ther; 1997 Mar; 8(5):597-613. PubMed ID: 9095411
[No Abstract] [Full Text] [Related]
14. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
15. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
[TBL] [Abstract][Full Text] [Related]
16. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
[TBL] [Abstract][Full Text] [Related]
18. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro.
Vrionis FD; Wu JK; Qi P; Cano W; Cherington V
J Neurosurg; 1995 Oct; 83(4):698-704. PubMed ID: 7674020
[TBL] [Abstract][Full Text] [Related]
19. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy.
Howard BD; Kalthoff H; Fong TC
Ann N Y Acad Sci; 1999 Jun; 880():352-65. PubMed ID: 10415879
[TBL] [Abstract][Full Text] [Related]
20. Thymidine kinase-mediated killing of rat brain tumors.
Barba D; Hardin J; Ray J; Gage FH
J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
